Dr. Joshua A. Hill
Claim this profileFred Hutch/University of Washington Cancer Consortium
Studies Infections and Infestations
Studies Mediastinal Lymphoma
3 reported clinical trials
4 drugs studied
Affiliated Hospitals
Clinical Trials Joshua A. Hill is currently running
Remdesivir
for Respiratory Syncytial Virus Infection
This phase II trial tests how well remdesivir works for treatment of respiratory syncytial virus (RSV) infection of the upper respiratory tract in patients receiving cellular or bispecific antibody therapy. Cellular or bispecific antibody therapies cause suppression of the immune system, making infections more frequent and reducing the body's ability to fight the infections. RSV infections are one of the most common respiratory infections in immunocompromised individuals and can cause significant pneumonia and even death. Remdesivir is in a class of medications called antivirals. It works by stopping viruses from spreading in the body.
Recruiting1 award Phase 22 criteria
IVIG
for Infection Prevention After Lymphoma Treatment
This phase II trial compares the effects of immunoglobulin replacement therapy with a placebo for preventing infectious complications in patients receiving CD19 chimeric antigen receptor (CAR)-T cell therapy. Hypogammaglobulinemia is a common complication in patients who receive CD19 CAR-T cell therapy. This is a condition in which the level of immunoglobulins (antibodies) in the blood is low and the risk of infection is high. Immunoglobulin replacement therapy works by replacing the body's immunoglobulin G (IgG) antibodies with donor blood product derived IgG antibodies that may help prevent infection. IgG antibodies are often depleted as a result of CAR-T therapy. Giving immunoglobulin replacement therapy may prevent infectious complications in patients receiving CD19 CAR-T cell therapy.
Recruiting0 awards Phase 2
More about Joshua A. Hill
Clinical Trial Related1 year of experience running clinical trials · Led 3 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Joshua A. Hill has experience with
- Wistar Rabies Virus Strain PM-1503-3M Vaccine
- Anti-CD19-targeting CAR-T Cells
- Immune Globulin Infusion (Human), 10% Solution
- Remdesivir
Breakdown of trials Joshua A. Hill has run
Infections and Infestations
Mediastinal Lymphoma
B-Cell Lymphoma
Hematologic Malignancies
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Joshua A. Hill specialize in?
Joshua A. Hill focuses on Infections and Infestations and Mediastinal Lymphoma. In particular, much of their work with Infections and Infestations has involved treating patients, or patients who are undergoing treatment.
Is Joshua A. Hill currently recruiting for clinical trials?
Yes, Joshua A. Hill is currently recruiting for 2 clinical trials in Seattle Washington. If you're interested in participating, you should apply.
Are there any treatments that Joshua A. Hill has studied deeply?
Yes, Joshua A. Hill has studied treatments such as Wistar Rabies Virus Strain PM-1503-3M Vaccine, Anti-CD19-targeting CAR-T Cells, Immune Globulin Infusion (Human), 10% Solution.
What is the best way to schedule an appointment with Joshua A. Hill?
Apply for one of the trials that Joshua A. Hill is conducting.
What is the office address of Joshua A. Hill?
The office of Joshua A. Hill is located at: Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington 98109 United States. This is the address for their practice at the Fred Hutch/University of Washington Cancer Consortium.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.